TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study.

Matthew E Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.